Revenue
2022
2023
2024
2025
Avenue Therapeutics, Inc. (ATXI)
Price$0.407587Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2023
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $0 | $0 | $0 | — | — | — | — | — | — | — |
| Research & development | $1.0M | $6.6M | $6.1M | $2.7M | $1.3M | $2.9M | $22.2M | $17.7M | $6.7M | $1.3M | $961,000 |
| Operating expenses | $4.5M | $11.3M | $14.5M | $8.0M | — | — | — | — | — | — | — |
| Operating income | −$3.1M | −$11.3M | −$14.5M | −$8.0M | −$3.7M | −$5.2M | −$26.3M | −$21.8M | −$11.4M | −$2.4M | −$4.8M |
| Operating margin | −219.59% | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$3.3M | −$11.3M | −$10.2M | −$2.4M | — | — | — | — | — | — | — |
| EBITDA margin | −234.05% | — | — | — | — | — | — | — | — | — | — |
| Net income | −$2.9M | −$11.7M | −$10.5M | −$3.6M | −$3.7M | −$5.2M | −$25.9M | −$21.5M | −$12.3M | −$3.2M | −$5.2M |
| Net profit margin | −207.19% | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$0.93 | -$15.79 | -$73.48 | -$1.63 | -$0.22 | -$0.31 | -$1.65 | -$2.10 | -$1.85 | -$1.11 | -$1.93 |
| Diluted EPSper diluted share | -$0.93 | -$15.79 | -$73.48 | -$122.25 | -$0.22 | -$0.31 | -$1.65 | -$2.10 | -$1.85 | -$1.11 | -$1.93 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Fortress Biotech, Inc. | 439.73K |
MacLean Alexandra | 170K |
Jin David | 65K |
KRANZLER JAY D | 559 |
Herskowitz Neil | 97 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 2, 2024Form 4 | Herskowitz NeilDirector | SellCOMMON STOCK, PAR VALUE $0.0001 | 23 | $2.00 | $46.00 | 97 |
| Nov 5, 2024Form 4 | KRANZLER JAY DDirector | SellCOMMON STOCK, PAR VALUE $0.0001 | 61 | $2.24 | $136.64 | 559 |
| Sep 30, 2024Form 4 | KRANZLER JAY DDirector | BuyCOMMON STOCK, PAR VALUE $0.0001 | 497 | $2.50 | $1.2K | 620 |
| Sep 27, 2024Form 4 | KRANZLER JAY DDirector | BuyCOMMON STOCK, PAR VALUE $0.0001 | 3 | $2.40 | $7.20 | 123 |